Search - tctmd.com

Displaying 41 - 60 of 307

Sort: Relevancy | Date

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Yael L. Maxwell

January 13, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Yael L. Maxwell

December 13, 2024

News Daily News

Female-Specific Factors Don’t Enhance Common Risk Calculators

Caitlin E. Cox

December 10, 2024

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

News Daily News

AI-Measured Breast Artery Calcification Tied to CV Outcomes in Women

Todd Neale

October 07, 2024

News Daily News

High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVD

Michael O'Riordan

September 23, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Daily News

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

L.A. McKeown

July 25, 2024

Advertisement

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Aspirin Use for Primary Prevention Declining in US: NHANES

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

December 2024 Dispatch for the CV Team

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Female-Specific Factors Don’t Enhance Common Risk Calculators

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

TCTMD’s Top 10 Most Popular Stories for November 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

AI-Measured Breast Artery Calcification Tied to CV Outcomes in Women

High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVD

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content